Responses

Download PDFPDF
Heart rhythm disorders and pacemakers
Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Intravenous magnesium in rhythm control of atrial fibrillation

    Dear Editor,

    Thank you for the interest of Dr. Srikanth Vallurupalli on our meta- analysis. In response to his comments on rhythm conversion by intravenous magnesium, I would like to clarify the results of our meta-analysis to avoid misunderstanding.
    In the analysis of the efficacy of magnesium in converting atrial fibrillation to sinus rhythm, magnesium was compared to a placebo-control group...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Intravenous magnesium in rhythm control of atrial fibrillation

    Dear Editor,

    I read with interest the meta analysis by Ho et al on the use of intravenous magnesium to treat acute onset atrial fibrillation.

    In their analysis of the efficacy of magnesium in the conversion of atrial fibrillation to sinus rhythm, magnesium was compared to a control group which consists of both calcium channel antagonists and amiodarone. Calcium channel antagonists and beta blockers ar...

    Show More
    Conflict of Interest:
    None declared.